Skip to main content
HUONS CO., LTD. logo

HUONS CO., LTD. — Investor Relations & Filings

Ticker · 243070 ISIN · KR7243070000 KO Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2020-06-04 Regulatory Filings
Country KR South Korea
Listing KO 243070

About HUONS CO., LTD.

https://www.huons.com/en

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(HU007(나노복합점안제)의 독일 임상시험계획 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Huons) regarding the approval of a Phase III clinical trial in Germany. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) filings in the Korean market, which are used to disclose material events to investors. Since it does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2020-06-04 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 95% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (a conference call). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation materials themselves, and it is under 5,000 characters, it falls under the category of a Report Publication Announcement or general regulatory filing announcement. Given the specific nature of announcing an IR event, it is best classified as a Report Publication Announcement (RPA).
2020-05-26 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Huons' (주)휴온스 for the period from January 1, 2020, to March 31, 2020. It contains detailed financial information, company overview, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-13 Korean
투자판단관련주요경영사항(1%리도카인 주사제 5mL Vial 美 FDA 제네릭 품목허가(ANDA승인))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Huons regarding the US FDA approval (ANDA) of their 1% Lidocaine injection. It is a specific corporate announcement regarding a material business event (regulatory approval for a product), which does not fit into financial reporting, shareholder meetings, or dividend categories. Given the nature of the announcement as a regulatory disclosure of a material event, it falls under the RNS (Regulatory Filings) category.
2020-05-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Huons Global and related parties) due to stock dividends. This falls under the category of Major Shareholding Notification (MRQ), as it tracks significant ownership thresholds and changes in shareholding status.
2020-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by insiders (executives and major shareholders) to disclose changes in their shareholdings. This falls under the category of 'Director's Dealing' (DIRS) as it reports personal share transactions or changes in ownership by company insiders.
2020-04-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.